Acadia Pharma (ACAD) Post Q3 Loss of $0.25/Share; Plans NUPLAZID NDA in Q1 2015

Go back to Acadia Pharma (ACAD) Post Q3 Loss of $0.25/Share; Plans NUPLAZID NDA in Q1 2015